Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
7/2/15 Vertex (VRTX) Orkambi for Cystic Fibrosis (CF) Subscribers Only Subscribers Only Subscribers Only
7/1/15 Teva (TEVA) TV-45070 for Osteoarthritis Subscribers Only Subscribers Only Subscribers Only
7/1/15 Gilead (GILD) TAF/emtricitabine/rilpivirine for HIV / AIDS Subscribers Only Subscribers Only Subscribers Only
7/1/15 Clovis Oncology (CLVS) Rociletinib for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
6/30/15 Roche (ROG:VX) Sembragiline for Alzheimer's Disease (AD) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
07/03/15 Subscribers Only Subscribers Only Trial Data - Updated Results
07/03/15 Subscribers Only Subscribers Only Trial Data - Other
Now - 07/07/15 Subscribers Only Subscribers Only Patent - Expiration
Now - 07/07/15 Subscribers Only Subscribers Only Patent - Expiration
07/07/15 Subscribers Only Subscribers Only Patent - Expiration